STAAR Surgical Company (STAA) Stock

STAAR Surgical Company (STAA) is a Healthcare stock trading at $29.12 (as of 2026-06-18), with a market capitalization of $1.49B and a trailing P/E of -71.2. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

STAAR Surgical Company designs, develops, manufactures, markets, and sells implantable eye lenses and related delivery systems. Its product lines include implantable Collamer lenses and cataract intraocular lenses with corresponding injector systems, which it supplies to ophthalmic surgeons and other healthcare providers through direct sales and distributors.

Valuation — source: SEC EDGAR (first-party)
Price	$29.12
Market Cap	$1.49B
P/E Ratio	-71.2
EV / EBITDA	-74.3
Price / Book	4.22
Price / Sales	5.12
DCF Value (model)	$-10.68
DCF Upside vs Price	-136.7%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$239.44M
Net Margin	-33.6%
Return on Equity	-6.0%
Current Ratio	5.12
Revenue Growth (YoY)	119.6%
EPS Growth (YoY)	-109.1%
FCF Growth (YoY)	207.4%

Financial Health — source: SEC EDGAR
Altman Z-Score	8.09 (safe)

Valuation vs Sector & Industry
Stock P/E	-71.2
Sector P/E (Healthcare)	21.0
Industry P/E (Medical Equipment)	31.7
vs Sector	-439.5%
vs Industry	-324.2%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	BROADWOOD CAPITAL INC ($301.52M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Medical Equipment
CEO	Warren Foust
Employees	1,157
Country	US
IPO Date	1992-02-24

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.